Medical practitioner/ Anti-depressants Refer to product Refer to the individual Consent: Person with psychiatrist (where the information, but product information capacity to give consent or Very rarely used as a chemical restrictive practice is usually: but generally would their relative or guardian. restraint. Most commonly would be being used to include: amitriptyline, which is sometimes Sedation. If the person is resisting or • administer medical used as a behavioural restraint Observation objecting to the medication, • Falls. • treatment): Prescribes due to its sedative properties. including the consent of an appointed the medical treatment monitoring for guardian with relevant and contributes to the side effects powers as per Section 32 of PBSP and risk (when medication the Guardianship and assessment as required. commenced, Administration Act 1993 is PBS practitioner: increased, or also required. Develops the PBSP, ceased). Endorsement: The contributes to the risk Regular medical delegated restrictive • assessment. review. practices compliance officer. Environmental Restraints (this is not an exhaustive list) Note: It is important to note that a responsible’ as defined under the Consent to Medical Treatment and Palliative Care Act 1995 ‘person cannot consent to restricting or preventing free access to food/drink/other items owned by the person for whom they are consenting. However, an appointed guardian for lifestyle can consent to the restriction of certain food/drink/other items for health safety and/or welfare reasons even when the person objects. However, in circumstances where force or significant coercion is required to prevent access to the desired item(s) consideration may be given to powers as per Section 32 of the Guardianship and Administration 1993, usually Section 32 (1) (c). Restrictive Practice Recommended Consent and Potential Risks Prescribing Person(s) Example Controls Endorsement
Anti-depressants Very rarely used as a chemical restraint. Most commonly would be amitriptyline, which is sometimes used as a behavioural restraint due to its sedative properties. Refer to product information, but usually: • Sedation. • Falls. Refer to the individual product information but generally would include: • Observation including monitoring for side effects (when medication commenced, increased, or ceased). • Regular medical review. Medical practitioner/ psychiatrist (where the restrictive practice is being used to administer medical treatment): Prescribes the medical treatment and contributes to the PBSP and risk assessment as required. PBS practitioner: Develops the PBSP, contributes to the risk assessment. Consent: Person with capacity to give consent or their relative or guardian. If the person is resisting or objecting to the medication, the consent of an appointed guardian with relevant powers as per Section 32 of the Guardianship and Administration Act 1993 is also required. Endorsement: The delegated restrictive practices compliance officer. Environmental Restraints (this is not an exhaustive list) Note: It is important to note that a ‘person responsible’ as defined under the Consent to Medical Treatment and Palliative Care Act 1995 cannot consent to restricting or preventing free access to food/drink/other items owned by the person for whom they are consenting. However, an appointed guardian for lifestyle can consent to the restriction of certain food/drink/other items for health safety and/or welfare reasons even when the person objects. However, in circumstances where force or significant coercion is required to prevent access to the desired item(s) consideration may be given to powers as per Section 32 of the Guardianship and Administration 1993, usually Section 32 (1) (c). Restrictive Practice Example Potential Risks Recommended Controls Prescribing Person(s) Consent and Endorsement
restrictive-practices-reference-guide-south-australian-disability-sector.docx